Advertisement
Research Article

Broad-Spectrum Antiviral Therapeutics

  • Todd H. Rider mail,

    thor@LL.MIT.EDU

    Affiliation: Lincoln Laboratory, Massachusetts Institute of Technology, Lexington, Massachusetts, United States of America

    X
  • Christina E. Zook,

    Affiliation: Lincoln Laboratory, Massachusetts Institute of Technology, Lexington, Massachusetts, United States of America

    X
  • Tara L. Boettcher,

    Affiliation: Lincoln Laboratory, Massachusetts Institute of Technology, Lexington, Massachusetts, United States of America

    X
  • Scott T. Wick,

    Affiliation: Lincoln Laboratory, Massachusetts Institute of Technology, Lexington, Massachusetts, United States of America

    X
  • Jennifer S. Pancoast,

    Affiliation: Lincoln Laboratory, Massachusetts Institute of Technology, Lexington, Massachusetts, United States of America

    X
  • Benjamin D. Zusman

    Affiliation: Lincoln Laboratory, Massachusetts Institute of Technology, Lexington, Massachusetts, United States of America

    X
  • Published: July 27, 2011
  • DOI: 10.1371/journal.pone.0022572

Reader Comments (7)

Post a new comment on this article

Impact

Posted by jbclam on 17 Jul 2012 at 14:11 GMT

I hate asking this question, but given the high level of publicity this work has received in the general media (thus raising so much hope in the general population), one has to ask: why is this a PlosONE paper and not a higher impact work? I cannot think of any one (especially from MIT) lightly sending what looks like a Nobel prize league work to PlosONE. I respect Plos One, but one usually send there good work that did not meet its public elsewhere. The reason is usually a series of controls asked by the reviewers that the authors declined doing. I am not suggesting everything should go into Science or Nature that have issues of their own, but I insist that we should know why apparently top work is making it there. In fact, I would be quite in favor of papers having universal identifiers, so that when they eventually get published one can read ALL the reservations reviewers had, across all submitted journals. For a paper like this one, this would certainly be instructive.

No competing interests declared.